Patients who had six or more gabapentin prescriptions were 85% more likely to experience mild cognitive impairment, and 29% were at higher risk for dementia.
Healthesystems Manager of Clinical Services, Britten Featherston, shares with WorkCompWire how formularies are powerful tools in effectively managing the unique needs of injured worker populations.
Dihydroergotamine mesylate injections are approved for the acute treatment of migraine with or without aura, and for the acute treatment of cluster headaches.
Healthe’s Kristine Kennedy speaks with Risk and Insurance magazine about how digital communication tools and emerging technologies are changing the landscape of workers’ comp.
